Kamada (KMDA) Revenue & Revenue Breakdown
Kamada Revenue Highlights
Latest Revenue (Y)
$144.76M
Latest Revenue (Q)
$37.40M
Main Geography (Y)
Other Foreign Countries Member
Kamada Revenue by Period
Kamada Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $144.76M | 11.92% |
2022-12-31 | $129.34M | 24.79% |
2021-12-31 | $103.64M | -22.22% |
2020-12-31 | $133.25M | 4.76% |
2019-12-31 | $127.19M | 11.11% |
2018-12-31 | $114.47M | 11.32% |
2017-12-31 | $102.83M | 32.69% |
2016-12-31 | $77.49M | 10.53% |
2015-12-31 | $70.11M | -2.52% |
2014-12-31 | $71.92M | 1.84% |
2013-12-31 | $70.62M | -2.82% |
2012-12-31 | $72.67M | 29.96% |
2011-12-31 | $55.92M | 54.16% |
2010-12-31 | $36.27M | 142.16% |
2009-12-31 | $14.98M | -1.54% |
2008-12-31 | $15.21M | 13.22% |
2007-12-31 | $13.44M | - |
Kamada Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $37.40M | -2.48% |
2023-12-31 | $38.35M | 1.10% |
2023-09-30 | $37.93M | 1.31% |
2023-06-30 | $37.44M | 21.92% |
2023-03-31 | $30.71M | -32.41% |
2022-12-31 | $45.44M | 41.04% |
2022-09-30 | $32.22M | 36.57% |
2022-06-30 | $23.59M | -16.03% |
2022-03-31 | $28.09M | -10.73% |
2021-12-31 | $31.47M | 36.62% |
2021-09-30 | $23.03M | -4.97% |
2021-06-30 | $24.24M | -2.65% |
2021-03-31 | $24.90M | -21.06% |
2020-12-31 | $31.54M | -10.71% |
2020-09-30 | $35.33M | 6.76% |
2020-06-30 | $33.09M | -0.60% |
2020-03-31 | $33.29M | 3.80% |
2019-12-31 | $32.07M | -3.01% |
2019-09-30 | $33.07M | -6.20% |
2019-06-30 | $35.25M | 31.56% |
2019-03-31 | $26.80M | -44.42% |
2018-12-31 | $48.21M | 221.94% |
2018-09-30 | $14.97M | -55.75% |
2018-06-30 | $33.84M | 94.04% |
2018-03-31 | $17.44M | -51.16% |
2017-12-31 | $35.71M | 55.82% |
2017-09-30 | $22.92M | -29.59% |
2017-06-30 | $32.55M | 179.44% |
2017-03-31 | $11.65M | -51.98% |
2016-12-31 | $24.26M | 25.22% |
2016-09-30 | $19.37M | 1.61% |
2016-06-30 | $19.07M | 28.85% |
2016-03-31 | $14.80M | -42.80% |
2015-12-31 | $25.87M | 60.98% |
2015-09-30 | $16.07M | -16.51% |
2015-06-30 | $19.25M | 115.52% |
2015-03-31 | $8.93M | -64.18% |
2014-12-31 | $24.93M | 45.37% |
2014-09-30 | $17.15M | 8.56% |
2014-06-30 | $15.80M | 19.79% |
2014-03-31 | $13.19M | -46.03% |
2013-12-31 | $24.43M | 39.77% |
2013-09-30 | $17.48M | 8.47% |
2013-06-30 | $16.11M | 27.94% |
2013-03-31 | $12.60M | -41.80% |
2012-12-31 | $21.64M | 22.43% |
2012-09-30 | $17.68M | 28.55% |
2012-06-30 | $13.75M | - |
Kamada Revenue Breakdown
Kamada Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Latin America | $12.93M | $3.79M | - | - | - |
CANADA | $11.16M | - | - | - | - |
Asia | $6.15M | $2.07M | - | - | - |
Other Foreign Countries Member | $31.30M | $32.03M | - | - | - |
Other Countries Member | $157.00K | $305.00K | - | - | - |
Foreign countries | - | $75.85M | $49.76M | $84.95M | - |
OtherForeignCountriesTwoMember | - | - | $9.13M | $6.87M | - |
OtherForeignCountriesThreeMember | - | - | $5.68M | $4.46M | - |
OtherForeignCountriesOneMember | - | - | $3.17M | $766.00K | - |
OtherForeignCountriesMember | - | - | $35.77M | $36.14M | - |
OtherCountriesMember | - | - | $134.00K | $59.00K | - |
US | - | - | - | - | $84.57M |
Europe | - | - | - | - | $4.70M |
Israel | - | - | - | - | $31.96M |
Others | - | - | - | - | $96.00K |
Quarterly Revenue by Country
Country | Dec 21 | Sep 21 |
---|---|---|
OtherForeignCountriesThreeMember | $4.58M | $1.10M |
OtherCountriesMember | $53.00K | $81.00K |
ISRAEL | - | $849.00K |
Latin America | - | $1.65M |
UNITED STATES | - | $12.71M |
Asia | - | $734.00K |
Kamada Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RDY | Dr. Reddy's Laboratories | $279.16B | - |
PRGO | Perrigo Company | $4.66B | $1.07B |
PBH | Prestige Consumer Healthcare | $1.13B | $267.14M |
PAHC | Phibro Animal Health | $977.89M | $263.22M |
PCRX | Pacira BioSciences | $674.98M | $178.02M |
COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
IRWD | Ironwood Pharmaceuticals | $442.74M | $94.40M |
ORGO | Organogenesis | $433.14M | $130.23M |
EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
KMDA | Kamada | $144.76M | $37.40M |
LFCR | Lifecore Biomedical | $128.26M | $24.70M |
ALIM | Alimera Sciences | $80.75M | $23.01M |
CPIX | Cumberland Pharmaceuticals | $39.55M | $9.85M |
AGRX | Agile Therapeutics | $19.59M | $5.58M |
GHSI | Guardion Health Sciences | $12.25M | $36.35K |
EVOK | Evoke Pharma | $5.18M | $1.74M |
AKAN | Akanda | $2.16M | $762.61K |
LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
SHPH | Shuttle Pharmaceuticals | - | - |
KMDA Revenue FAQ
What is Kamada’s yearly revenue?
Kamada's yearly revenue for 2023 was $144.76M, representing an increase of 11.92% compared to 2022. The company's yearly revenue for 2022 was $129.34M, representing an increase of 24.79% compared to 2021. KMDA's yearly revenue for 2021 was $103.64M, representing a decrease of -22.22% compared to 2020.
What is Kamada’s quarterly revenue?
Kamada's quarterly revenue for Q1 2024 was $37.4M, a -2.48% decrease from the previous quarter (Q4 2023), and a 21.78% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $38.35M, a 1.10% increase from the previous quarter (Q3 2023), and a -15.60% decrease year-over-year (Q4 2022). KMDA's quarterly revenue for Q3 2023 was $37.93M, a 1.31% increase from the previous quarter (Q2 2023), and a 17.75% increase year-over-year (Q3 2022).
What is Kamada’s revenue growth rate?
Kamada's revenue growth rate for the last 3 years (2021-2023) was 39.67%, and for the last 5 years (2019-2023) was 13.82%.